Zimmer Biomet Holdings ROA 2006-2020 | ZBH

Current and historical return on assets (ROA) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Zimmer Biomet Holdings ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-06-30 $0.04B $23.65B 0.15%
2020-03-31 $0.38B $25.51B 1.53%
2019-12-31 $1.13B $24.64B 4.65%
2019-09-30 $-0.09B $24.32B -0.37%
2019-06-30 $-0.36B $24.21B -1.47%
2019-03-31 $-0.31B $24.29B -1.24%
2018-12-31 $-0.38B $24.13B -1.48%
2018-09-30 $1.75B $25.38B 6.74%
2018-06-30 $1.69B $25.49B 6.43%
2018-03-31 $1.69B $27.18B 6.37%
2017-12-31 $1.81B $26.01B 6.85%
2017-09-30 $0.65B $26.42B 2.45%
2017-06-30 $0.71B $26.46B 2.66%
2017-03-31 $0.50B $26.99B 1.86%
2016-12-31 $0.31B $26.68B 1.16%
2016-09-30 $0.36B $27.04B 1.37%
2016-06-30 $0.23B $25.97B 0.86%
2016-03-31 $0.08B $26.30B 0.31%
2015-12-31 $0.15B $27.16B 0.59%
2015-09-30 $0.17B $26.69B 0.83%
2015-06-30 $0.32B $27.20B 2.00%
2015-03-31 $0.67B $17.19B 5.81%
2014-12-31 $0.72B $9.66B 7.52%
2014-09-30 $0.83B $9.67B 8.64%
2014-06-30 $0.81B $9.64B 8.52%
2014-03-31 $0.78B $9.38B 8.37%
2013-12-31 $0.78B $9.58B 8.48%
2013-09-30 $0.68B $9.36B 7.49%
2013-06-30 $0.70B $9.10B 7.88%
2013-03-31 $0.77B $8.75B 8.70%
2012-12-31 $0.76B $9.01B 8.64%
2012-09-30 $0.76B $8.78B 8.81%
2012-06-30 $0.77B $8.62B 9.12%
2012-03-31 $0.76B $8.60B 9.09%
2011-12-31 $0.76B $8.52B 9.21%
2011-09-30 $0.64B $8.20B 7.86%
2011-06-30 $0.64B $8.25B 7.90%
2011-03-31 $0.60B $8.12B 7.52%
2010-12-31 $0.60B $8.00B 7.54%
2010-09-30 $0.72B $8.00B 9.12%
2010-06-30 $0.68B $7.83B 8.70%
2010-03-31 $0.72B $7.82B 9.38%
2009-12-31 $0.72B $7.79B 9.52%
2009-09-30 $0.73B $7.65B 9.87%
2009-06-30 $0.80B $7.46B 10.96%
2009-03-31 $0.81B $7.23B 11.40%
2008-12-31 $0.85B $7.24B 12.05%
2008-09-30 $0.95B $7.08B 13.71%
2008-06-30 $0.78B $6.94B 11.54%
2008-03-31 $0.78B $6.92B 11.89%
2007-12-31 $0.77B $6.63B 12.18%
2007-09-30 $0.76B $6.37B 12.20%
2007-06-30 $0.89B $6.32B 14.70%
2007-03-31 $0.86B $6.10B 14.40%
2006-12-31 $0.84B $5.97B 14.05%
2006-09-30 $0.79B $5.91B 13.44%
2006-06-30 $0.78B $5.96B 13.36%
2006-03-31 $0.77B $5.92B 13.43%
2005-12-31 $0.73B $5.72B 13.06%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $28.616B $7.982B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $175.389B 32.91
Medtronic (MDT) Ireland $135.096B 21.94
Stryker (SYK) United States $70.813B 27.46
Boston Scientific (BSX) United States $56.240B 32.49
Lonza Group Ag (LZAGY) Switzerland $44.026B 0.00
Baxter (BAX) United States $41.987B 25.68
Terumo (TRUMY) Japan $29.409B 37.59
EssilorLuxottica Societe Anonyme (ESLOY) France $28.260B 0.00
ResMed (RMD) United States $25.025B 36.34
Sunny Optical Technology (SNPTF) China $20.071B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.905B 0.00
Bio-Rad Laboratories (BIO) United States $14.731B 66.62
Insulet (PODD) United States $13.054B 552.33
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.631B 51.02
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.229B 12.40
Hill-Rom Holdings (HRC) United States $6.398B 15.88
Canopy Growth (CGC) Canada $6.287B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.378B 0.00
Neogen (NEOG) United States $4.135B 69.09
Haemonetics (HAE) United States $4.050B 26.99
ICU Medical (ICUI) United States $4.048B 30.88
Envista Holdings (NVST) United States $3.688B 25.15
Abcam (ABCZY) $3.604B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.409B 0.00
National Vision Holdings (EYE) United States $2.831B 440.00
Agios Pharmaceuticals (AGIO) United States $2.792B 0.00
NuVasive (NUVA) United States $2.755B 38.40
DFB Healthcare Acquisitions (AHCO) United States $2.045B 188.38
TG Therapeutics (TGTX) United States $2.036B 0.00
AtriCure (ATRC) United States $1.843B 0.00
MacroGenics (MGNX) United States $1.447B 0.00
NanoString Technologies (NSTG) United States $1.356B 0.00
Aphria (APHA) Canada $1.281B 0.00
Aurora Cannabis (ACB) Canada $1.157B 0.00
Cerus (CERS) United States $1.138B 0.00
Cardiovascular Systems (CSII) United States $1.096B 0.00
InMode (INMD) Israel $0.995B 25.10
OraSure Technologies (OSUR) United States $0.960B 0.00
Quanterix (QTRX) United States $0.950B 0.00
Owens & Minor (OMI) United States $0.945B 21.17
Lantheus Holdings (LNTH) United States $0.914B 12.67
Omeros (OMER) United States $0.866B 0.00
PetIQ (PETQ) United States $0.832B 24.04
Phibro Animal Health (PAHC) United States $0.790B 15.76
Meridian Bioscience (VIVO) United States $0.750B 17.32
Vapotherm (VAPO) United States $0.742B 0.00
Surmodics (SRDX) United States $0.645B 70.73
VAREX IMAGING (VREX) United States $0.637B 15.81
BioLife Solutions (BLFS) United States $0.634B 330.33
Zynex (ZYXI) United States $0.623B 54.39
Eagle Pharmaceuticals (EGRX) United States $0.587B 82.92
LeMaitre Vascular (LMAT) United States $0.586B 35.79
Cytosorbents (CTSO) United States $0.401B 0.00
Viemed Healthcare (VMD) United States $0.399B 14.25
Neptune Wellness Solutions (NEPT) Canada $0.343B 0.00
HEXO (HEXO) $0.327B 0.00
Utah Medical Products (UTMD) $0.300B 25.71
InfuSystems Holdings (INFU) United States $0.258B 143.11
Organigram Holdings (OGI) Canada $0.234B 0.00
Female Health (VERU) United States $0.207B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Exagen (XGN) United States $0.181B 0.00
Bovie Medical (APYX) United States $0.178B 0.00
Fonar (FONR) United States $0.171B 15.14
Surface Oncology (SURF) United States $0.168B 0.00
Wound Management Technologies (SMTI) United States $0.167B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Evolus (EOLS) United States $0.126B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.125B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
Capricor Therapeutics (CAPR) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
United-Guardian (UG) United States $0.073B 16.35
Nephros (NEPH) United States $0.071B 0.00
Brainsway (BWAY) Israel $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
Akers Biosciences Inc (AKER) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00